Author:
Muralha Adriana,Vianna Raul N. G.
Publisher
Springer International Publishing
Reference5 articles.
1. Bernardes TP, Foresto RD, Kirsztajn GM. Fabry disease: genetics, pathology, and treatment. Rev Assoc Med Bras. 2020;66:s10–6. http://www.scielo.br/j/ramb/a/KZVkfdZ7MDXvwjMjpm9nsLx/?lang=en
2. Rodriguez-Gonzalez-Herrero ME, Marín-sánchez JM, Gimeno JR, Molero-Izquierdo C, De-Casas-Fernández A, Rodríguez-González-Herrero B, et al. Ophthalmological manifestations in Fabry’s disease. Four clinical cases showing deficient alpha-galactosidase-A activity. Arch Soc Esp Oftalmol. 2008;83(12):713–8. https://pubmed.ncbi.nlm.nih.gov/19085643/
3. Marques MG, Mira F, Ferreira E, Pinto H, Maia P, Mendes T, et al. Fabry’s disease, an eye-kidney disease review. Port J Nephrol Hypert. 2015;29:15–20.
4. Bacherini D, Vicini G, Nicolosi C, Tanini I, Lenzetti C, Finocchio L, et al. Optical coherence tomography angiography for the evaluation of retinal vasculature in Fabry disease: our experience and review of current knowledge. Front Neurol. 2021;9:12. https://pubmed.ncbi.nlm.nih.gov/33767663/
5. Sivley MD, Benjamin WJ. Fabry keratopathy: manifestations and changes over time. Br J Ophthalmol. 2020;104(8):1148–55. https://pubmed.ncbi.nlm.nih.gov/31666224/